GCL
AMRI

Glazer Capital LLC’s Albany Molecular Research Inc AMRI Stock Holding History

Glazer Capital LLC’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-437,864
Closed -$9.5M – 102
2017
Q2 		$9.5M Buy
+437,864
New +$7.95M 0.61% 35

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Glazer Capital LLC's AMRI Position: Q3 2017 in Review

Glazer Capital LLC sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 437,864 shares — an estimated $9.5M sold.

Glazer Capital LLC first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $9.5M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Glazer Capital LLC reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Glazer Capital LLC sold 437,864 Albany Molecular Research Inc shares in Q3 2017, an estimated $9.5M.
  • Glazer Capital LLC first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • Glazer Capital LLC's Albany Molecular Research Inc position peaked at $9.5M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Glazer Capital LLC's 13F filing for Q3 2017, filed 14 Nov 2017.